Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs
Pharmaceuticals · 04.04.2023 · 16 (4) · 543
DOI: 10.3390/ph16040543 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 04.04.2023. Verfasst von Carlos Gaona-López und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional.
Abstract (Originalsprache)
Protozoan parasite diseases cause significant mortality and morbidity worldwide. Factors such as climate change, extreme poverty, migration, and a lack of life opportunities lead to the propagation of diseases classified as tropical or non-endemic. Although there are several drugs to combat parasitic diseases, strains resistant to routinely used drugs have been reported. In addition, many first-line drugs have adverse effects ranging from mild to severe, including potential carcinogenic effects. Therefore, new lead compounds are needed to combat these parasites. Although little has been studied regarding the epigenetic mechanisms in lower eukaryotes, it is believed that epigenetics plays an essential role in vital aspects of the organism, from controlling the life cycle to the expression of genes involved in pathogenicity. Therefore, using epigenetic targets to combat these parasites is foreseen as an area with great potential for development. This review summarizes the main known epigenetic mechanisms and their potential as therapeutics for a group of medically important protozoal parasites. Different epigenetic mechanisms are discussed, highlighting those that can be used for drug repositioning, such as histone post-translational modifications (HPTMs). Exclusive parasite targets are also emphasized, including the base J and DNA 6 mA. These two categories have the greatest potential for developing drugs to treat or eradicate these diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.
- Departamento de Parasitología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Laboratorio de Estudios Epidemiológicos, Clínicos, Diseños Experimentales e Investigación, Facultad de Ciencias Químicas, Universidad Autónoma "Benito Juárez" de Oaxaca, Avenida Universidad S/N, Ex Hacienda Cinco Señore…
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Francisco Villa 20, General Escobedo 66054, Mexico.
- Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
ORCID-Profile: Lenci K Vazquez-Jimenez, Timoteo Delgado-Maldonado, Benjamín Nogueda-Torres, Adriana Moreno-Rodríguez, Emma Saavedra, Gildardo Rivera
Förderung
- Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional
Zitieren
APA
Gaona-López, C., Vazquez-Jimenez, L. K., Gonzalez-Gonzalez, A., Delgado-Maldonado, T., Ortiz-Pérez, E., Nogueda-Torres, B., Moreno-Rodríguez, A., Vázquez, K., Saavedra, E., & Rivera, G. (2023). Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs. Pharmaceuticals, 16(4), 543. https://doi.org/10.3390/ph16040543
Vancouver
Gaona-López C, Vazquez-Jimenez LK, Gonzalez-Gonzalez A, Delgado-Maldonado T, Ortiz-Pérez E, Nogueda-Torres B, et al. Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs. Pharmaceuticals. 2023;16(4):543. doi:10.3390/ph16040543
BibTeX
@article{GaonaLpez2023,
author = {Gaona-López, Carlos and Vazquez-Jimenez, Lenci K and Gonzalez-Gonzalez, Alonzo and Delgado-Maldonado, Timoteo and Ortiz-Pérez, Eyrá and Nogueda-Torres, Benjamín and Moreno-Rodríguez, Adriana and Vázquez, Karina and Saavedra, Emma and Rivera, Gildardo},
title = {Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {4},
pages = {543},
doi = {10.3390/ph16040543}
}
EUVIMED